Mechanism of action of antihypertensive agents.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002415:Cats; D003000:Clonidine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005246:Feedback; D006168:Guinea Pigs; D006321:Heart / Q000294:innervation; D006801:Humans; D051379:Mice; D008771:Nordefrin / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D009778:Occipital Lobe / Q000033:anatomy & histology; D011651:Pulmonary Artery / Q000294:innervation; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D011945:Receptors, Angiotensin / Q000187:drug effects; D012504:Saralasin / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D012504:Saralasin; D003000:Clonidine; D008771:Nordefrin; D009638:Norepinephrine; D004837:Epinephrine